U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The blockbuster diabetes and weight-loss drug semaglutide (Ozempic, Rybelsus, Wegovy) along with therapies for asthma, ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...

The popular weight-loss drugs were added to Medicare’s list of prices negotiated directly between the government and drug ...

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has ...

Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.